| Title | Date | Type | Setname | ||
|---|---|---|---|---|---|
| 101 |
 |
Visual Field Loss in Children With Sporadic and Neurofibromatosis Type 1 (NF1)-Associated Optic Pathway Gliomas: Baseline Characteristics From a Multicenter, Prospective Natural History Study | 2023-03 | Text | ehsl_novel_nam |
| 102 |
 |
Visual Field Outcomes in Optic Pathway Glioma After Bevacizumab Therapy | 2022-02 | Text | ehsl_novel_nam |
| 103 |
 |
Visual Hallucinations | Text | ehsl_novel_nam | |
| 104 |
 |
Visual Outcome Following Fractionated Stereotactic Radiotherapy of Anterior Visual Pathway Meningiomas: Conventional vs. Hypofractionated | 2021-02 | Text | ehsl_novel_nam |
| 105 |
 |
Visual Outcomes in Neurofibromatosis Type-1 Patients With Optic Pathway Gliomas at a Tertiary Cancer Center | 2022-02 | Text | ehsl_novel_nam |
| 106 |
 |
Visual Pathway Dysgerminoma Mimicking Neuromyelitis Optica | 2022-02 | Text | ehsl_novel_nam |
| 107 |
 |
Volcano Instead of Light at the End of the Tunnel | 2022-02 | Text | ehsl_novel_nam |
| 108 |
 |
Walsh & Hoyt: Tumors | 2005 | Text | ehsl_novel_whts |
| 109 |
 |
Walsh & Hoyt: Tumors | 2005 | Text | ehsl_novel_whts |